Novo Nordisk has bounced back from a sour ending to its Hims & Hers partnership, revealing a new deal with WeightWatchers to ...

With midyear approaching, the main Wall Street stock indexes are back within a hair's breadth of new records, helped along by ...

Dr. Ambish Mithal unpacks the world of new-age weight management drugs, their side effects, their benefits and what lies ...

The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...

The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in ...

Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Patients prescribed Mounjaro - dubbed the 'King Kong' of injections due to its potency - took to social media concerned they ...

At least 10 people have now died following side-effects allegedly caused by GLP-1 weight loss jabs. Over a million people ...

SoftBank's Son Lays Out Vision to Be No. 1 in Artificial Superintelligence SoftBank's investment plans have come under scrutiny as Japan tries to close a deal with the Trump administration. There's a ...

Access is opening up for Kiwis to a weight loss drug described as a game changer. Wegovy, made by pharma-co Novo Nordisk, ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...